Crohn's disease (CD) and eosinophilic gastrointestinal diseases (EGIDs) are distinct inflammatory entities, but eosinophilic disease may emerge as a paradoxical immune complication of anti-tumor necrosis factor therapy. This evidence concerns the gene TNF and eosinophil disorder.